The role of Tim‐3/Galectin‐9 pathway in T‐cell function and prognosis of patients with human papilloma virus‐associated cervical carcinoma

Cervical cancer prevention in China: a key to cancer control

(2019) Fanghui Zhao et al.   LANCET

Distinct prognostic value of circulating anti-telomerase CD4+ Th1 immunity and exhausted PD-1+/TIM-3+ T cells in lung cancer

(2019) Caroline Laheurte et al.   BRITISH JOURNAL OF CANCER

Role of Regulatory B Cells in the Progression of Cervical Cancer

(2019) Zhifang Chen et al.   MEDIATORS OF INFLAMMATION

The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer

(2019) Inna M. Yasinska et al.   Frontiers in Immunology

Infiltrating CD4 and CD8 lymphocytes in HPV infected uterine cervical milieu

(2019) Ninu Maskey et al.   Cancer Management and Research

Cervical Cancer as a Global Concern

(2019) Carla J. Chibwesha et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Immune Checkpoint Blockade Mediated by a Small‐Molecule Nanoinhibitor Targeting the PD‐1/PD‐L1 Pathway Synergizes with Photodynamic Therapy to Elicit Antitumor Immunity and Antimetastatic Effects on Breast Cancer

(2019) Rui Zhang et al.   Small

Differential effect of GLUT1 overexpression on survival and tumor immune microenvironment of human papilloma virus type 16-positive and -negative cervical cancer

(2019) Byoung Hyuck Kim et al.   Scientific Reports

TCR Repertoire Diversity of Peripheral PD-1+CD8+ T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non–Small Cell Lung Cancer

(2019) Jiefei Han et al.   Cancer Immunology Research

PD-1 and PD-L1 inhibitors in oesophago-gastric cancers

(2019) Tugba Akin Telli et al.   CANCER LETTERS

TIM-3 expression identifies a distinctive PD-1 + follicular helper T cell subset, with reduced interleukin 21 production and B cell help function in ovarian cancer patients

(2018) Li Li et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Evaluation of immune responses induced by a novel human papillomavirus type 16 E7 peptide-based vaccine with Candida skin test reagent as an adjuvant in C57BL/6 mice

(2018) Xingxuan Wang et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Characterization of TIM-3 expression and its prognostic value in patients with surgically resected lung adenocarcinoma

(2018) Hang Su et al.   LUNG CANCER

Long non-coding RNA Lnc-Tim3 exacerbates CD8 T cell exhaustion via binding to Tim-3 and inducing nuclear translocation of Bat3 in HCC

(2018) Jie Ji et al.   Cell Death & Disease

Tim-3 and its role in regulating anti-tumor immunity

(2017) Madhumita Das et al.   IMMUNOLOGICAL REVIEWS

Elevated Galectin-9 Suppresses Th1 Effector Function and Induces Apoptosis of Activated CD4+ T Cells in Osteoarthritis

(2017) Shufeng Yang et al.   INFLAMMATION

Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status

(2017) Junlong Wu et al.   Scientific Reports

Elevated Expression of Programmed Death-1 and Programmed Death Ligand-1 Negatively Regulates Immune Response against Cervical Cancer Cells

(2016) Zhifang Chen et al.   MEDIATORS OF INFLAMMATION

Hepatitis C viral infection is associated with activated cytolytic natural killer cells expressing high levels of T cell immunoglobulin- and mucin-domain-containing molecule-3.

(2015) Lucy Golden-Mason et al.   CLINICAL IMMUNOLOGY

Recipient T cell TIM-3 and hepatocyte galectin-9 signalling protects mouse liver transplants against ischemia-reperfusion injury

(2015) Yuanxing Liu et al.   JOURNAL OF HEPATOLOGY

T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survival

(2015) Meng Yang et al.   JOURNAL OF SURGICAL ONCOLOGY

IL-10 inhibits neuraminidase-activated TGF-β and facilitates Th1 phenotype during early phase of infection

(2015) Avijit Dutta et al.   Nature Communications

Tim-3 blocking rescue macrophage and T cell function against Mycobacterium tuberculosis infection in HIV+ patients

(2015) Isabel Sada-Ovalle et al.   Journal of the International AIDS Society

Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer

(2015) Chiao-Wen Kang et al.   Scientific Reports

A role for the TIM-3/GAL-9/BAT3 pathway in determining the clinical phenotype of multiple sclerosis

(2014) Marina Saresella et al.   FASEB JOURNAL

Prognostic Value of T Cell Immunoglobulin Mucin-3 in Prostate Cancer

(2013) Yong-Rui Piao et al.   Asian Pacific Journal of Cancer Prevention

The Th17/Treg balance and the expression of related cytokines in Uygur cervical cancer patients

(2013) Zhifang Chen et al.   Diagnostic Pathology

The Tim-3/galectin-9 pathway involves in the homeostasis of hepatic Tregs in a mouse model of concanavalin A-induced hepatitis

(2013) Ying Ju et al.   MOLECULAR IMMUNOLOGY

Tim-3 Expression in Cervical Cancer Promotes Tumor Metastasis

(2013) Yang Cao et al.   PLoS One

HCV-infected hepatocytes drive CD4+CD25+Foxp3+regulatory T-cell development through the Tim-3/Gal-9 pathway

(2012) Xiao J. Ji et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma

(2012) Hang Li et al.   HEPATOLOGY

T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses

(2011) S. Sharma et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA